Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Regulatory News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.75
Bid: 14.50
Ask: 15.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.45%)
Open: 14.75
High: 14.75
Low: 14.75
Yest. Close: 14.75
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Issue of Share Options

Wed, 30th Oct 2019 07:00

>
RNS Number : 5376R
Yourgene Health PLC
30 October 2019
 

 Yourgene Health plc

("Yourgene Health" or the "Company")

 

Issue of Share Options

 

Manchester, UK - 30 October 2019: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces the issuance of share options to a recently appointed Non-executive Director and new members of the Company's senior management team.

 

The new share options below have performance conditions based on EPS growth over the next three years, in line with other senior incentives and previously issued share options:

 

Name

New options issued

Jonathan Seaton

1,500,000

Other individuals

1,000,000

 

The exercise price of these options is 12 pence.  The total number of share options now in issue is 68,504,961, representing 10% of the as-enlarged share capital.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Yourgene Health plc

Lyn Rees, Chief Executive Officer

Barry Hextall, Chief Financial Officer

Joanne Cross, Director of Marketing

 

Tel: +44 (0)161 667 1053

investors@yourgene-health.com

 

Cairn Financial Advisers LLP (NOMAD)

Liam Murray / James Caithie / Ludovico Lazzaretti

 

Tel: +44 (0)20 7213 0880

Stifel Nicolaus Europe Limited (Sole Corporate Broker)

Nicholas Moore / Matthew Blawat / Ben Maddison

 

Tel: +44 (0)20 7710 7600

Walbrook PR Ltd (Media and Investor Relations)

Lianne Cawthorne / Alice Woodings

Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com

Mob: 07980 541 893 / 07407 804 654

 

     

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 

 

Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

 

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.

 

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Jonathan Seaton

 

2

Reason for notification

  

a.

Position/Status

Non-executive Director

 

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Yourgene Health plc

b.

LEI

213800UUIT8BZE7QEH33

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Options over ordinary shares of 0.1p each

 

ISIN: GB00BN31ZD89

b.

Nature of the transaction

Grant of share options

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

12.00p

1,500,000

 

 

 

e.

Date of the transaction

29 October 2019

f.

Place of the transaction

UK

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUKSBRKOARUAA
Date   Source Headline
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test

Login to your account

Don't have an account? Click here to register.